机构：[1]Division of Abdominal Tumor Multimodality Treatment and Laboratory of Cell Engineering and Immunotherapy, Cancer Center and State Key Laboratory of Respiratory Health and Multimorbidity and Frontiers Science Center for Disease-related Molecular Network, West China Hospital, Sichuan University, Chengdu, Sichuan, China四川大学华西医院[2]General (specialized) Department, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital& Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of University of Electronic Science and Technology of China, Chengdu, China四川省肿瘤医院[3]Department of Rehabilitation Medicine, The First Affiliated Hospital of Xi’an Jiaotong University, Xi’an, Shaanxi province, P.R. China[4]Shandong Provincial Key Laboratory of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China.
第一作者机构：[1]Division of Abdominal Tumor Multimodality Treatment and Laboratory of Cell Engineering and Immunotherapy, Cancer Center and State Key Laboratory of Respiratory Health and Multimorbidity and Frontiers Science Center for Disease-related Molecular Network, West China Hospital, Sichuan University, Chengdu, Sichuan, China
共同第一作者：
推荐引用方式(GB/T 7714)：
Zhu Yongjie,Sun Ruipu,Fan Jiawei,et al.CSF1-CAR Specifically Targets CSF1R+ Pancreatic Cancer Cells and Tumor-Associated Macrophages[J].Journal Of Immunotherapy (Hagerstown, Md. : 1997).2025,48(7):237-243.doi:10.1097/CJI.0000000000000563.
APA：
Zhu Yongjie,Sun Ruipu,Fan Jiawei,Ma Haiyan&Sun Bin.(2025).CSF1-CAR Specifically Targets CSF1R+ Pancreatic Cancer Cells and Tumor-Associated Macrophages.Journal Of Immunotherapy (Hagerstown, Md. : 1997),48,(7)
MLA：
Zhu Yongjie,et al."CSF1-CAR Specifically Targets CSF1R+ Pancreatic Cancer Cells and Tumor-Associated Macrophages".Journal Of Immunotherapy (Hagerstown, Md. : 1997) 48..7(2025):237-243
